Globus Medical GMED Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Product | ||||||
| Enabling Technologies | $26.87M+21.1% | —— | —— | —— | $22.19M-42.4% | |
| Musculoskeletal Solutions | $732.98M+27.3% | —— | —— | —— | $575.93M-2.6% | |
| Net Sales by Geography | ||||||
| International | $154.97M+35.6% | $161.1M+19.0% | $151.42M+16.5% | $144.56M+11.0% | $114.26M-7.7% | |
| United States | $604.89M+25.0% | $665.32M+27.5% | $617.63M+24.6% | $600.78M+20.3% | $483.86M+0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Globus Medical break its business down?
- Globus Medical (GMED) reports net sales by product across 2 parts — Enabling Technologies and Musculoskeletal Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Globus Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Globus Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
